{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T18:23:40Z","timestamp":1790965420928,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,31]]},"DOI":"10.7759\/cureus.78298","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T14:53:42Z","timestamp":1738335222000},"source":"Crossref","is-referenced-by-count":10,"title":["Alopecia Areata: Understanding the Pathophysiology and Advancements in Treatment Modalities"],"prefix":"10.7759","author":[{"given":"Yozahandy A","family":"Abarca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee","family":"Scott-Emuakpor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jhanavi","family":"Tirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oksana","family":"Moroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George Pandarakalam","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Yateem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Golbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninigail","family":"Aphia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Lysak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niketa","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Humza F","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-021-08883-0","article-title":"Alopecia areata: an update on etiopathogenesis, diagnosis, and management","volume":"61","author":"Zhou C","year":"2021","unstructured":"Zhou C, Li X, Wang C, Zhang J. Alopecia areata: an update on etiopathogenesis, diagnosis, and management. Clin Rev Allergy Immunol. 2021, 61:403-23. 10.1007\/s12016-021-08883-0","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2023.09.008","article-title":"Alopecia areata: what's new in the epidemiology, comorbidities, and pathogenesis?","volume":"112","author":"Dainichi T","year":"2023","unstructured":"Dainichi T, Iwata M, Kaku Y. Alopecia areata: what's new in the epidemiology, comorbidities, and pathogenesis?. J Dermatol Sci. 2023, 112:120-7. 10.1016\/j.jdermsci.2023.09.008","journal-title":"J Dermatol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S331579","article-title":"Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata","volume":"14","author":"Chanprapaph K","year":"2021","unstructured":"Chanprapaph K, Mahasaksiri T, Kositkuljorn C, Leerunyakul K, Suchonwanit P. Prevalence and risk factors associated with the occurrence of autoimmune diseases in patients with alopecia areata. J Inflamm Res. 2021, 14:4881-91. 10.2147\/JIR.S331579","journal-title":"J Inflamm Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-020-00673-w","article-title":"Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options","volume":"21","author":"Sterkens A","year":"2021","unstructured":"Sterkens A, Lambert J, Bervoets A. Alopecia areata: a review on diagnosis, immunological etiopathogenesis and treatment options. Clin Exp Med. 2021, 21:215-30. 10.1007\/s10238-020-00673-w","journal-title":"Clin Exp Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2147\/ITT.S266409","article-title":"Alopecia areata: an autoimmune disease of multiple players","volume":"10","author":"Suchonwanit P","year":"2021","unstructured":"Suchonwanit P, Kositkuljorn C, Pomsoong C. Alopecia areata: an autoimmune disease of multiple players. Immunotargets Ther. 2021, 10:299-312. 10.2147\/ITT.S266409","journal-title":"Immunotargets Ther"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2023.4661","article-title":"Alopecia areata","volume":"160","author":"Gaurav A","year":"2024","unstructured":"Gaurav A, Eang B, Mostaghimi A. Alopecia areata. JAMA Dermatol. 2024, 160:372. 10.1001\/jamadermatol.2023.4661","journal-title":"JAMA Dermatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16839","article-title":"Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database","volume":"50","author":"George P","year":"2023","unstructured":"George P, Jagun O, Liu Q, et al.. Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database. J Dermatol. 2023, 50:1121-8. 10.1111\/1346-8138.16839","journal-title":"J Dermatol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0250216","article-title":"Alopecia areata is not a risk factor for heart diseases: a 10-year retrospective cohort study","volume":"16","author":"Lee H","year":"2021","unstructured":"Lee H, Kim YC, Choi JW. Alopecia areata is not a risk factor for heart diseases: a 10-year retrospective cohort study. PLoS One. 2021, 16:e0250216. 10.1371\/journal.pone.0250216","journal-title":"PLoS One"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004413.pub2","article-title":"Interventions for alopecia areata","author":"Delamere FM","year":"2008","unstructured":"Delamere FM, Sladden MM, Dobbins HM, Leonardi-Bee J. Interventions for alopecia areata. Cochrane Database Syst Rev. 2008, CD004413. 10.1002\/14651858.CD004413.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.04.1141","article-title":"Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis","volume":"78","author":"Strazzulla LC","year":"2018","unstructured":"Strazzulla LC, Wang EH, Avila L, Lo Sicco K, Brinster N, Christiano AM, Shapiro J. Alopecia areata: disease characteristics, clinical evaluation, and new perspectives on pathogenesis. J Am Acad Dermatol. 2018, 78:1-12. 10.1016\/j.jaad.2017.04.1141","journal-title":"J Am Acad Dermatol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2019.08.032","article-title":"Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis","volume":"82","author":"Lee HH","year":"2020","unstructured":"Lee HH, Gwillim E, Patel KR, Hua T, Rastogi S, Ibler E, Silverberg JI. Epidemiology of alopecia areata, ophiasis, totalis, and universalis: a systematic review and meta-analysis. J Am Acad Dermatol. 2020, 82:675-82. 10.1016\/j.jaad.2019.08.032","journal-title":"J Am Acad Dermatol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/ddg.14689","article-title":"Alopecia areata - current understanding and management","volume":"20","author":"Lintzeri DA","year":"2022","unstructured":"Lintzeri DA, Constantinou A, Hillmann K, Ghoreschi K, Vogt A, Blume-Peytavi U. Alopecia areata - current understanding and management. J Dtsch Dermatol Ges. 2022, 20:59-90. 10.1111\/ddg.14689","journal-title":"J Dtsch Dermatol Ges"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.4103\/0974-7753.125608","article-title":"Clinical and dermatoscopic patterns of alopecia areata: a tertiary care centre experience","volume":"5","author":"Hegde SP","year":"2013","unstructured":"Hegde SP, Naveen KN, Athanikar SB, Reshme P. Clinical and dermatoscopic patterns of alopecia areata: a tertiary care centre experience. Int J Trichology. 2013, 5:132-6. 10.4103\/0974-7753.125608","journal-title":"Int J Trichology"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/12034754231168839","article-title":"Alopecia areata: an updated review for 2023","volume":"27","author":"Sibbald C","year":"2023","unstructured":"Sibbald C. Alopecia areata: an updated review for 2023. J Cutan Med Surg. 2023, 27:241-59. 10.1177\/12034754231168839","journal-title":"J Cutan Med Surg"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1159\/000510880","article-title":"Demographic and clinical features of 1,641 patients with alopecia areata, alopecia totalis, and alopecia universalis: a single-center retrospective study","volume":"7","author":"Uzuncakmak TK","year":"2021","unstructured":"Uzuncakmak TK, Engin B, Serdaroglu S, Tuzun Y. Demographic and clinical features of 1,641 patients with alopecia areata, alopecia totalis, and alopecia universalis: a single-center retrospective study. Skin Appendage Disord. 2021, 7:8-12. 10.1159\/000510880","journal-title":"Skin Appendage Disord"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.13064","article-title":"Alopecia areata predictive score: a new trichoscopy-based tool to predict treatment outcome in patients with patchy alopecia areata","volume":"19","author":"Wa\u015bkiel-Burnat A","year":"2020","unstructured":"Wa\u015bkiel-Burnat A, Rakowska A, Sikora M, Olszewska M, Rudnicka L. Alopecia areata predictive score: a new trichoscopy-based tool to predict treatment outcome in patients with patchy alopecia areata. J Cosmet Dermatol. 2020, 19:746-51. 10.1111\/jocd.13064","journal-title":"J Cosmet Dermatol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.2174\/0118743722280092240126053902","article-title":"Insights into alopecia areata: a systematic review of prevalence, pathogenesis, and psychological consequences","volume":"18","author":"Bahashwan E","year":"2024","unstructured":"Bahashwan E, Alshehri M. Insights into alopecia areata: a systematic review of prevalence, pathogenesis, and psychological consequences. Open Dermatol J. 2024, 18:1-12. 10.2174\/0118743722280092240126053902","journal-title":"Open Dermatol J"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s12016-017-8620-9","article-title":"Alopecia areata: a comprehensive review of pathogenesis and management","volume":"54","author":"Tr\u00fceb RM","year":"2018","unstructured":"Tr\u00fceb RM, Dias MF. Alopecia areata: a comprehensive review of pathogenesis and management. Clin Rev Allergy Immunol. 2018, 54:68-87. 10.1007\/s12016-017-8620-9","journal-title":"Clin Rev Allergy Immunol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.crimmu.2021.02.001","article-title":"Immunopathogenesis of alopecia areata","volume":"2","author":"Olayinka JJ","year":"2021","unstructured":"Olayinka JJ, Richmond JM. Immunopathogenesis of alopecia areata. Curr Res Immunol. 2021, 2:7-11. 10.1016\/j.crimmu.2021.02.001","journal-title":"Curr Res Immunol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.21608\/smj.2021.67540.1236","article-title":"Updates in the pathogenesis of alopecia areata","volume":"25","author":"Gouda ZAB","year":"2021","unstructured":"Gouda ZAB, Nada E, Assaf HA, Aboeldahab SH. Updates in the pathogenesis of alopecia areata. Sohag Med J. 2021, 25:31-41. 10.21608\/smj.2021.67540.1236","journal-title":"Sohag Med J"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25115652","article-title":"Deciphering the complex immunopathogenesis of alopecia areata","volume":"25","author":"\u0160uti\u0107 Udovi\u0107 I","year":"2024","unstructured":"\u0160uti\u0107 Udovi\u0107 I, Hla\u010da N, Massari LP, Brajac I, Ka\u0161telan M, Vi\u010di\u0107 M. Deciphering the complex immunopathogenesis of alopecia areata. Int J Mol Sci. 2024, 25:10.3390\/ijms25115652","journal-title":"Int J Mol Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.33235\/wpr.30.1.24-33","article-title":"Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape","volume":"30","author":"Moussa A","year":"2022","unstructured":"Moussa A, Bokhari L, Sinclair RD. Alopecia areata: a review of diagnosis, pathogenesis and the therapeutic landscape. Wound Pract Res. 2022, 30:24-33. 10.33235\/wpr.30.1.24-33","journal-title":"Wound Pract Res"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2004.05915.x","article-title":"The genetic epidemiology of alopecia areata in China","volume":"151","author":"Yang S","year":"2004","unstructured":"Yang S, Yang J, Liu JB, et al.. The genetic epidemiology of alopecia areata in China. Br J Dermatol. 2004, 151:16-23. 10.1111\/j.1365-2133.2004.05915.x","journal-title":"Br J Dermatol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.02.006","article-title":"Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors","volume":"62","author":"Rodriguez TA","year":"2010","unstructured":"Rodriguez TA, Fernandes KE, Dresser KL, Duvic M. Concordance rate of alopecia areata in identical twins supports both genetic and environmental factors. J Am Acad Dermatol. 2010, 62:525-7. 10.1016\/j.jaad.2009.02.006","journal-title":"J Am Acad Dermatol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms6966","article-title":"Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci","volume":"6","author":"Betz RC","year":"2015","unstructured":"Betz RC, Petukhova L, Ripke S, et al.. Genome-wide meta-analysis in alopecia areata resolves HLA associations and reveals two new susceptibility loci. Nat Commun. 2015, 6:5966. 10.1038\/ncomms6966","journal-title":"Nat Commun"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/nature09114","article-title":"Genome-wide association study in alopecia areata implicates both innate and adaptive immunity","volume":"466","author":"Petukhova L","year":"2010","unstructured":"Petukhova L, Duvic M, Hordinsky M, et al.. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010, 466:113-17. 10.1038\/nature09114","journal-title":"Nature"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12412584","article-title":"Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata","volume":"103","author":"Welsh EA","year":"1994","unstructured":"Welsh EA, Clark HH, Epstein SZ, Reveille JD, Duvic M. Human leukocyte antigen-DQB1*03 alleles are associated with alopecia areata. J Invest Dermatol. 1994, 103:758-63. 10.1111\/1523-1747.ep12412584","journal-title":"J Invest Dermatol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.15419\/bmrat.v8i10.702","article-title":"Evaluation of serum levels of IL-6, IL-10, and TNF-alpha in alopecia areata patients: a systematic review and meta-analysis","volume":"31","author":"Torkestani S","year":"2021","unstructured":"Torkestani S, Moghimi H, Farsiabi R, Khazaei S, Eftekharian MM, Dalvand E. Evaluation of serum levels of IL-6, IL-10, and TNF-alpha in alopecia areata patients: a systematic review and meta-analysis. Biomed Res J. 2021, 31:4668-78. 10.15419\/bmrat.v8i10.702","journal-title":"Biomed Res J"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1089\/jir.2013.0055","article-title":"Association between interleukin 18 polymorphisms and alopecia areata in Koreans","volume":"34","author":"Kim SK","year":"2014","unstructured":"Kim SK, Park HJ, Chung JH, Kim JW, Seok H, Lew BL, Sim WY. Association between interleukin 18 polymorphisms and alopecia areata in Koreans. J Interferon Cytokine Res. 2014, 34:349-53. 10.1089\/jir.2013.0055","journal-title":"J Interferon Cytokine Res"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.5021\/ad.2012.24.1.61","article-title":"Association between IL17A\/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population","volume":"24","author":"Lew BL","year":"2012","unstructured":"Lew BL, Cho HR, Haw S, Kim HJ, Chung JH, Sim WY. Association between IL17A\/IL17RA gene polymorphisms and susceptibility to alopecia areata in the Korean population. Ann Dermatol. 2012, 24:61-5. 10.5021\/ad.2012.24.1.61","journal-title":"Ann Dermatol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncrna.2024.08.005","article-title":"LncRNA NEAT1 and miRNA 101 as potential diagnostic biomarkers in patients with alopecia areata","volume":"10","author":"Erfan R","year":"2025","unstructured":"Erfan R, Shaker OG, Khalil MA, et al.. LncRNA NEAT1 and miRNA 101 as potential diagnostic biomarkers in patients with alopecia areata. Noncoding RNA Res. 2025, 10:35-40. 10.1016\/j.ncrna.2024.08.005","journal-title":"Noncoding RNA Res"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14473","article-title":"Diagnostic implications of MicroRNAs; 155, 146 a, and 203 lesional expression in alopecia areata: a preliminary case-controlled study","volume":"21","author":"Mustafa AI","year":"2022","unstructured":"Mustafa AI, Al-Refaie AM, El-Shimi OS, Fawzy E, Sorour NE. Diagnostic implications of MicroRNAs; 155, 146 a, and 203 lesional expression in alopecia areata: a preliminary case-controlled study. J Cosmet Dermatol. 2022, 21:2648-54. 10.1111\/jocd.14473","journal-title":"J Cosmet Dermatol"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000037300","article-title":"Interleukin gene polymorphisms and alopecia areata: a systematic review and meta-analysis","volume":"103","author":"Tishe ZH","year":"2024","unstructured":"Tishe ZH, Shawkat S, Popy MN, Ahmed A, Mumu SB, Apu MN, Mostaid MS. Interleukin gene polymorphisms and alopecia areata: a systematic review and meta-analysis. Medicine (Baltimore). 2024, 103:e37300. 10.1097\/MD.0000000000037300","journal-title":"Medicine (Baltimore)"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28343-3","article-title":"Whole exome sequencing in alopecia areata identifies rare variants in KRT82","volume":"13","author":"Erjavec SO","year":"2022","unstructured":"Erjavec SO, Gelfman S, Abdelaziz AR, et al.. Whole exome sequencing in alopecia areata identifies rare variants in KRT82. Nat Commun. 2022, 13:800. 10.1038\/s41467-022-28343-3","journal-title":"Nat Commun"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2020.102810","article-title":"Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss","volume":"57","author":"Oka A","year":"2020","unstructured":"Oka A, Takagi A, Komiyama E, et al.. Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss. EBioMedicine. 2020, 57:102810. 10.1016\/j.ebiom.2020.102810","journal-title":"EBioMedicine"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0258499","article-title":"Effect of PTPN22, FAS\/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: a systematic review of the literature and meta-analysis","volume":"16","author":"Gil-Qui\u00f1ones SR","year":"2021","unstructured":"Gil-Qui\u00f1ones SR, Sep\u00falveda-Pach\u00f3n IT, S\u00e1nchez Vanegas G, Gutierrez-Casta\u00f1eda LD. Effect of PTPN22, FAS\/FASL, IL2RA and CTLA4 genetic polymorphisms on the risk of developing alopecia areata: a systematic review of the literature and meta-analysis. PLoS One. 2021, 16:e0258499. 10.1371\/journal.pone.0258499","journal-title":"PLoS One"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbih.2021.100279","article-title":"Skin-brain axis signaling mediates behavioral changes after skin wounding","volume":"15","author":"Fregoso DR","year":"2021","unstructured":"Fregoso DR, Hadian Y, Gallegos AC, et al.. Skin-brain axis signaling mediates behavioral changes after skin wounding. Brain Behav Immun Health. 2021, 15:100279. 10.1016\/j.bbih.2021.100279","journal-title":"Brain Behav Immun Health"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2020.03.008","article-title":"Stress-induced interaction of skin immune cells, hormones, and neurotransmitters","volume":"42","author":"Pondeljak N","year":"2020","unstructured":"Pondeljak N, Lugovi\u0107-Mihi\u0107 L. Stress-induced interaction of skin immune cells, hormones, and neurotransmitters. Clin Ther. 2020, 42:757-70. 10.1016\/j.clinthera.2020.03.008","journal-title":"Clin Ther"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.14416","article-title":"Alopecia areata: a psychodermatological perspective","volume":"21","author":"Torales J","year":"2022","unstructured":"Torales J, Castaldelli-Maia JM, Ventriglio A, et al.. Alopecia areata: a psychodermatological perspective. J Cosmet Dermatol. 2022, 21:2318-23. 10.1111\/jocd.14416","journal-title":"J Cosmet Dermatol"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241411711","article-title":"Psychological stress-induced pathogenesis of alopecia areata: autoimmune and apoptotic pathways","volume":"24","author":"Ahn D","year":"2023","unstructured":"Ahn D, Kim H, Lee B, Hahm DH. Psychological stress-induced pathogenesis of alopecia areata: autoimmune and apoptotic pathways. Int J Mol Sci. 2023, 24:11711. 10.3390\/ijms241411711","journal-title":"Int J Mol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-92616-8_2","article-title":"The immunogenetics of alopecia areata","volume":"1367","author":"Rajabi F","year":"2022","unstructured":"Rajabi F, Abdollahimajd F, Jabalameli N, Nassiri Kashani M, Firooz A. The immunogenetics of alopecia areata. Adv Exp Med Biol. 2022, 1367:19-59. 10.1007\/978-3-030-92616-8_2","journal-title":"Adv Exp Med Biol"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.06.047","article-title":"Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review","volume":"85","author":"Toussi A","year":"2021","unstructured":"Toussi A, Barton VR, Le ST, Agbai ON, Kiuru M. Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: a systematic review. J Am Acad Dermatol. 2021, 85:162-75. 10.1016\/j.jaad.2020.06.047","journal-title":"J Am Acad Dermatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-020-00547-7","article-title":"Cigarette smoking, alcohol consumption, and risk of alopecia areata: a population-based cohort study in Taiwan","volume":"21","author":"Dai YX","year":"2020","unstructured":"Dai YX, Yeh FY, Shen YJ, et al.. Cigarette smoking, alcohol consumption, and risk of alopecia areata: a population-based cohort study in Taiwan. Am J Clin Dermatol. 2020, 21:901-11. 10.1007\/s40257-020-00547-7","journal-title":"Am J Clin Dermatol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15898","article-title":"Association between smoking and alopecia areata: a systematic review and meta-analysis","volume":"61","author":"Khanimov I","year":"2022","unstructured":"Khanimov I. Association between smoking and alopecia areata: a systematic review and meta-analysis. Int J Dermatol. 2022, 61:e22-4. 10.1111\/ijd.15898","journal-title":"Int J Dermatol"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031038","article-title":"Lifestyle factors involved in the pathogenesis of alopecia areata","volume":"23","author":"Minokawa Y","year":"2022","unstructured":"Minokawa Y, Sawada Y, Nakamura M. Lifestyle factors involved in the pathogenesis of alopecia areata. Int J Mol Sci. 2022, 23:1038. 10.3390\/ijms23031038","journal-title":"Int J Mol Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph192013126","article-title":"The impact of sleep quality on mood status and quality of life in patients with alopecia areata: a comparative study","volume":"19","author":"S\u00e1nchez-D\u00edaz M","year":"2022","unstructured":"S\u00e1nchez-D\u00edaz M, D\u00edaz-Calvillo P, Soto-Moreno A, Molina-Leyva A, Arias-Santiago S. The impact of sleep quality on mood status and quality of life in patients with alopecia areata: a comparative study. Int J Environ Res Public Health. 2022, 19:13126. 10.3390\/ijerph192013126","journal-title":"Int J Environ Res Public Health"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2020.06.015","article-title":"Bidirectional association between alopecia areata and sleep disorders: a population-based cohort study in Taiwan","volume":"75","author":"Dai YX","year":"2020","unstructured":"Dai YX, Tai YH, Chen CC, Chang YT, Chen TJ, Chen MH. Bidirectional association between alopecia areata and sleep disorders: a population-based cohort study in Taiwan. Sleep Med. 2020, 75:112-16. 10.1016\/j.sleep.2020.06.015","journal-title":"Sleep Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.5021\/ad.22.136","article-title":"Evaluation of sleep disturbance in alopecia areata through questionnaire: Pittsburgh Sleep Quality Index as a reasonable tool","volume":"35","author":"Park SH","year":"2023","unstructured":"Park SH, Ji KH, Kim JU, et al.. Evaluation of sleep disturbance in alopecia areata through questionnaire: Pittsburgh Sleep Quality Index as a reasonable tool. Ann Dermatol. 2023, 35:183-9. 10.5021\/ad.22.136","journal-title":"Ann Dermatol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.5021\/ad.20.084","article-title":"Alopecia areata and body mass index: a retrospective analysis of 257 cases","volume":"34","author":"Lee YB","year":"2022","unstructured":"Lee YB, Lee WS. Alopecia areata and body mass index: a retrospective analysis of 257 cases. Ann Dermatol. 2022, 34:305-8. 10.5021\/ad.20.084","journal-title":"Ann Dermatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-92853-1","article-title":"Adiponectin as a novel biomarker of disease severity in alopecia areata","volume":"11","author":"Stochmal A","year":"2021","unstructured":"Stochmal A, Wa\u015bkiel-Burnat A, Chrostowska S, Zaremba M, Rakowska A, Czuwara J, Rudnicka L. Adiponectin as a novel biomarker of disease severity in alopecia areata. Sci Rep. 2021, 11:13809. 10.1038\/s41598-021-92853-1","journal-title":"Sci Rep"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1159\/000504786","article-title":"The role of diet as an adjuvant treatment in scarring and nonscarring alopecia","volume":"6","author":"Pham CT","year":"2020","unstructured":"Pham CT, Romero K, Almohanna HM, Griggs J, Ahmed A, Tosti A. The role of diet as an adjuvant treatment in scarring and nonscarring alopecia. Skin Appendage Disord. 2020, 6:88-96. 10.1159\/000504786","journal-title":"Skin Appendage Disord"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/nu14030591","article-title":"The role of nutrition in immune-mediated, inflammatory skin disease: a narrative review","volume":"14","author":"Diotallevi F","year":"2022","unstructured":"Diotallevi F, Campanati A, Martina E, et al.. The role of nutrition in immune-mediated, inflammatory skin disease: a narrative review. Nutrients. 2022, 14:591. 10.3390\/nu14030591","journal-title":"Nutrients"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1111\/jocd.15994","article-title":"Inverse correlation between vitamin D and CRP levels in alopecia areata: a pilot study","volume":"22","author":"Mokhtari F","year":"2023","unstructured":"Mokhtari F, Ganjei Z, Yazdanpanah M, Hosseini M. Inverse correlation between vitamin D and CRP levels in alopecia areata: a pilot study. J Cosmet Dermatol. 2023, 22:3176-80. 10.1111\/jocd.15994","journal-title":"J Cosmet Dermatol"},{"key":"ref54","article-title":"The gut and skin microbiome in alopecia: associations and interventions","volume":"16","author":"Carrington AE","year":"2023","unstructured":"Carrington AE, Maloh J, Nong Y, Agbai ON, Bodemer AA, Sivamani RK. The gut and skin microbiome in alopecia: associations and interventions. J Clin Aesthet Dermatol. 2023, 16:59-64.","journal-title":"J Clin Aesthet Dermatol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.3390\/genes13101860","article-title":"How our microbiome influences the pathogenesis of alopecia areata","volume":"13","author":"S\u00e1nchez-Pellicer P","year":"2022","unstructured":"S\u00e1nchez-Pellicer P, Navarro-Moratalla L, N\u00fa\u00f1ez-Delegido E, Ag\u00fcera-Santos J, Navarro-L\u00f3pez V. How our microbiome influences the pathogenesis of alopecia areata. Genes (Basel). 2022, 13:1860. 10.3390\/genes13101860","journal-title":"Genes (Basel)"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/microorganisms10050864","article-title":"A potential predictive role of the scalp microbiome profiling in patients with alopecia areata: Staphylococcus caprae, Corynebacterium, and Cutibacterium species","volume":"10","author":"Won EJ","year":"2022","unstructured":"Won EJ, Jang HH, Park H, Kim SJ. A potential predictive role of the scalp microbiome profiling in patients with alopecia areata: Staphylococcus caprae, Corynebacterium, and Cutibacterium species. Microorganisms. 2022, 10:864. 10.3390\/microorganisms10050864","journal-title":"Microorganisms"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1281660","article-title":"Gut microbiome, metabolome and alopecia areata","volume":"14","author":"Liu Z","year":"2023","unstructured":"Liu Z, Liu X. Gut microbiome, metabolome and alopecia areata. Front Microbiol. 2023, 14:1281660. 10.3389\/fmicb.2023.1281660","journal-title":"Front Microbiol"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.15885","article-title":"Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers","volume":"34","author":"Moreno-Arrones OM","year":"2020","unstructured":"Moreno-Arrones OM, Serrano-Villar S, Perez-Brocal V, et al.. Analysis of the gut microbiota in alopecia areata: identification of bacterial biomarkers. J Eur Acad Dermatol Venereol. 2020, 34:400-5. 10.1111\/jdv.15885","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-024-01956-8","article-title":"Alopecia areata following COVID-19 vaccine: a systematic review","volume":"29","author":"Zhu Y","year":"2024","unstructured":"Zhu Y, Ouyang X, Zhang D, et al.. Alopecia areata following COVID-19 vaccine: a systematic review. Eur J Med Res. 2024, 29:356. 10.1186\/s40001-024-01956-8","journal-title":"Eur J Med Res"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.16207","article-title":"Alopecia areata: current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines","volume":"49","author":"Fukuyama M","year":"2022","unstructured":"Fukuyama M, Ito T, Ohyama M. Alopecia areata: current understanding of the pathophysiology and update on therapeutic approaches, featuring the Japanese Dermatological Association guidelines. J Dermatol. 2022, 49:19-36. 10.1111\/1346-8138.16207","journal-title":"J Dermatol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.17014","article-title":"A cross-sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system","volume":"63","author":"Ravipati A","year":"2024","unstructured":"Ravipati A, Pradeep T, Tosti A. A cross-sectional analysis of medications used by patients reporting alopecia areata on the FDA adverse events reporting system. Int J Dermatol. 2024, 63:497-502. 10.1111\/ijd.17014","journal-title":"Int J Dermatol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2017.01.060","article-title":"Commonly prescribed medications associated with alopecia","volume":"88","author":"Mounessa J","year":"2023","unstructured":"Mounessa J, Caravaglio JV, Domozych R, Chapman S, Dellavalle RP, Dunnick CA, Norris D. Commonly prescribed medications associated with alopecia. J Am Acad Dermatol. 2023, 88:1326-37.e2. 10.1016\/j.jaad.2017.01.060","journal-title":"J Am Acad Dermatol"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.2147\/JIR.S427937","article-title":"Alopecia universalis in an elderly Chinese man induced by sacubitril\/Alisartan, a novel angiotensin receptor-neprilysin inhibitor","volume":"16","author":"Teng Y","year":"2023","unstructured":"Teng Y, Fan Y, Shang D, Tao X, Sun D. Alopecia universalis in an elderly Chinese man induced by sacubitril\/Alisartan, a novel angiotensin receptor-neprilysin inhibitor. J Inflamm Res. 2023, 16:3519-22. 10.2147\/JIR.S427937","journal-title":"J Inflamm Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.36849\/JDD.6690","article-title":"Rituximab-induced alopecia universalis in a patient with bullous pemphigoid","volume":"21","author":"Puiu T","year":"2022","unstructured":"Puiu T, Reimer D, Sokumbi O. Rituximab-induced alopecia universalis in a patient with bullous pemphigoid. J Drugs Dermatol. 2022, 21:894-5. 10.36849\/JDD.6690","journal-title":"J Drugs Dermatol"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2023.04.022","article-title":"Medication-induced hair loss: an update","volume":"89","author":"Alhanshali L","year":"2023","unstructured":"Alhanshali L, Buontempo M, Shapiro J, Lo Sicco K. Medication-induced hair loss: an update. J Am Acad Dermatol. 2023, 89:S20-8. 10.1016\/j.jaad.2023.04.022","journal-title":"J Am Acad Dermatol"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1111\/ced.14381","article-title":"Drug-induced alopecia areata?","volume":"46","author":"Murad A","year":"2021","unstructured":"Murad A, Maguire J, Bergfeld W. Drug-induced alopecia areata?. Clin Exp Dermatol. 2021, 46:363-6. 10.1111\/ced.14381","journal-title":"Clin Exp Dermatol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.abd.2020.05.006","article-title":"Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology","volume":"95 Suppl 1","author":"Ramos PM","year":"2020","unstructured":"Ramos PM, Anzai A, Duque-Estrada B, et al.. Consensus on the treatment of alopecia areata - Brazilian Society of Dermatology. An Bras Dermatol. 2020, 95 Suppl 1:39-52. 10.1016\/j.abd.2020.05.006","journal-title":"An Bras Dermatol"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1093\/ced\/llae085","article-title":"Efficacy and safety of topical corticosteroid treatment under occlusion for severe alopecia areata in children: a\u00a0single-centre retrospective analysis","volume":"49","author":"Lee YY","year":"2024","unstructured":"Lee YY, Lim HH, Son S, et al.. Efficacy and safety of topical corticosteroid treatment under occlusion for severe alopecia areata in children: a\u00a0single-centre retrospective analysis. Clin Exp Dermatol. 2024, 49:1125-30. 10.1093\/ced\/llae085","journal-title":"Clin Exp Dermatol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.15342","article-title":"A cross-sectional hospital study of erythroderma","volume":"60","author":"Ravi M","year":"2021","unstructured":"Ravi M, Trinidad J, Spaccarelli N, Kaffenberger BH. A cross-sectional hospital study of erythroderma. Int J Dermatol. 2021, 60:e203-5. 10.1111\/ijd.15342","journal-title":"Int J Dermatol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3671","article-title":"Management of alopecia areata","volume":"341","author":"Harries MJ","year":"2010","unstructured":"Harries MJ, Sun J, Paus R, King LE Jr. Management of alopecia areata. BMJ. 2010, 341:c3671. 10.1136\/bmj.c3671","journal-title":"BMJ"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.20351","article-title":"Janus kinase inhibitors for alopecia areata: a systematic review and meta-analysis","volume":"6","author":"Liu M","year":"2023","unstructured":"Liu M, Gao Y, Yuan Y, Yang K, Shen C, Wang J, Tian J. Janus kinase inhibitors for alopecia areata: a systematic review and meta-analysis. JAMA Netw Open. 2023, 6:e2320351. 10.1001\/jamanetworkopen.2023.20351","journal-title":"JAMA Netw Open"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.61878","article-title":"Comparison of efficacy of autologous platelet rich plasma therapy with 5% topical minoxidil spray in treating alopecia areata: a head-to-head assessment of novel approaches","volume":"16","author":"Muhammad A","year":"2024","unstructured":"Muhammad A, Saleem S, Khan S, et al.. Comparison of efficacy of autologous platelet rich plasma therapy with 5% topical minoxidil spray in treating alopecia areata: a head-to-head assessment of novel approaches. Cureus. 2024, 16:e61878. 10.7759\/cureus.61878","journal-title":"Cureus"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/s0190-9622(87)70095-4","article-title":"Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata","volume":"16","author":"Price VH","year":"1987","unstructured":"Price VH. Double-blind, placebo-controlled evaluation of topical minoxidil in extensive alopecia areata. J Am Acad Dermatol. 1987, 16:730-6. 10.1016\/s0190-9622(87)70095-4","journal-title":"J Am Acad Dermatol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_28_21","article-title":"An updated review on current treatment of alopecia areata and newer therapeutic options","volume":"15","author":"Malhotra K","year":"2023","unstructured":"Malhotra K, Madke B. An updated review on current treatment of alopecia areata and newer therapeutic options. Int J Trichology. 2023, 15:3-12. 10.4103\/ijt.ijt_28_21","journal-title":"Int J Trichology"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/ski2.441","article-title":"Topical immunotherapy with diphenylcyclopropenone in paediatric patients with alopecia areata-a retrospective study of 97 patients","volume":"4","author":"Esmaeili F","year":"2024","unstructured":"Esmaeili F, Vahabi SM, Abdoli M, et al.. Topical immunotherapy with diphenylcyclopropenone in paediatric patients with alopecia areata-a retrospective study of 97 patients. Skin Health Dis. 2024, 4:e441. 10.1002\/ski2.441","journal-title":"Skin Health Dis"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-018-0226-5","article-title":"Topical immunotherapy of alopecia areata: a large retrospective study","volume":"8","author":"Zerbinati N","year":"2018","unstructured":"Zerbinati N, Esposito C, D'Este E, Calligaro A, Valsecchi R. Topical immunotherapy of alopecia areata: a large retrospective study. Dermatol Ther (Heidelb). 2018, 8:101-10. 10.1007\/s13555-018-0226-5","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-023-01873-w","article-title":"Baricitinib for the treatment of alopecia areata","volume":"83","author":"Freitas E","year":"2023","unstructured":"Freitas E, Guttman-Yassky E, Torres T. Baricitinib for the treatment of alopecia areata. Drugs. 2023, 83:761-70. 10.1007\/s40265-023-01873-w","journal-title":"Drugs"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3390\/healthcare9111575","article-title":"Baricitinib: the first jak inhibitor approved in Europe for the treatment of moderate to severe atopic dermatitis in adult patients","volume":"9","author":"Radi G","year":"2021","unstructured":"Radi G, Simonetti O, Rizzetto G, Diotallevi F, Molinelli E, Offidani A. Baricitinib: the first jak inhibitor approved in Europe for the treatment of moderate to severe atopic dermatitis in adult patients. Healthcare (Basel). 2021, 9:1-20. 10.3390\/healthcare9111575","journal-title":"Healthcare (Basel)"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70032-d","article-title":"Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis","volume":"22","author":"Gupta AK","year":"1990","unstructured":"Gupta AK, Ellis CN, Cooper KD, et al.. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol. 1990, 22:242-50. 10.1016\/0190-9622(90)70032-d","journal-title":"J Am Acad Dermatol"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-020-00370-2","article-title":"Cyclosporine with and without systemic corticosteroids in treatment of alopecia areata: a systematic review","volume":"10","author":"Nowaczyk J","year":"2020","unstructured":"Nowaczyk J, Makowska K, Rakowska A, Sikora M, Rudnicka L. Cyclosporine with and without systemic corticosteroids in treatment of alopecia areata: a systematic review. Dermatol Ther (Heidelb). 2020, 10:387-99. 10.1007\/s13555-020-00370-2","journal-title":"Dermatol Ther (Heidelb)"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S376096","article-title":"Alopecia areata: burden of disease, approach to treatment, and current unmet needs","volume":"16","author":"Alhanshali L","year":"2023","unstructured":"Alhanshali L, Buontempo MG, Lo Sicco KI, Shapiro J. Alopecia areata: burden of disease, approach to treatment, and current unmet needs. Clin Cosmet Investig Dermatol. 2023, 16:803-20. 10.2147\/CCID.S376096","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.4103\/ijt.ijt_14_18","article-title":"Mesalazine in the treatment of extensive alopecia areata: a new therapeutic option?","volume":"13","author":"Kiszewski AE","year":"2018","unstructured":"Kiszewski AE, Bevilaqua M, De Abreu LB. Mesalazine in the treatment of extensive alopecia areata: a new therapeutic option?. Int J Trichology. 2018, 13:99-102. 10.4103\/ijt.ijt_14_18","journal-title":"Int J Trichology"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.3889\/oamjms.2019.097","article-title":"The effectiveness of oral mini-pulse methylprednisolonein - the treatment of alopecia areata in Vietnam","volume":"7","author":"Thi PT","year":"2019","unstructured":"Thi PT, Lan AT, Ha PT, et al.. The effectiveness of oral mini-pulse methylprednisolonein - the treatment of alopecia areata in Vietnam. Open Access Maced J Med Sci. 2019, 7:291-2. 10.3889\/oamjms.2019.097","journal-title":"Open Access Maced J Med Sci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061694","article-title":"Alopecia areata and dexamethasone mini-pulse therapy, a prospective cohort: real world evidence and factors related to successful response","volume":"11","author":"S\u00e1nchez-D\u00edaz M","year":"2022","unstructured":"S\u00e1nchez-D\u00edaz M, Montero-Vilchez T, Bueno-Rodriguez A, Molina-Leyva A, Arias-Santiago S. Alopecia areata and dexamethasone mini-pulse therapy, a prospective cohort: real world evidence and factors related to successful response. J Clin Med. 2022, 11:10.3390\/jcm11061694","journal-title":"J Clin Med"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S465963","article-title":"The roles of exosomes in regulating hair follicle growth","volume":"17","author":"Cheng M","year":"2024","unstructured":"Cheng M, Ma C, Chen HD, Wu Y, Xu XG. The roles of exosomes in regulating hair follicle growth. Clin Cosmet Investig Dermatol. 2024, 17:1603-12. 10.2147\/CCID.S465963","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-021-02614-0","article-title":"Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle","volume":"12","author":"Deng W","year":"2021","unstructured":"Deng W, Zhang Y, Wang W, et al.. Hair follicle-derived mesenchymal stem cells decrease alopecia areata mouse hair loss and reduce inflammation around the hair follicle. Stem Cell Res Ther. 2021, 12:548. 10.1186\/s13287-021-02614-0","journal-title":"Stem Cell Res Ther"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25179236","article-title":"Mesenchymal stem cell therapy in alopecia areata: visual and molecular evidence from a mouse model","volume":"25","author":"Park SH","year":"2024","unstructured":"Park SH, Song SW, Lee YJ, Kang H, Kim JE. Mesenchymal stem cell therapy in alopecia areata: visual and molecular evidence from a mouse model. Int J Mol Sci. 2024, 25:10.3390\/ijms25179236","journal-title":"Int J Mol Sci"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12030964","article-title":"Systematic review of psychological interventions for quality of life, mental health, and hair growth in alopecia areata and scarring alopecia","volume":"12","author":"Maloh J","year":"2023","unstructured":"Maloh J, Engel T, Natarelli N, Nong Y, Zufall A, Sivamani RK. Systematic review of psychological interventions for quality of life, mental health, and hair growth in alopecia areata and scarring alopecia. J Clin Med. 2023, 12:964. 10.3390\/jcm12030964","journal-title":"J Clin Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.331.7522.951","article-title":"The psychological impact of alopecia","volume":"331","author":"Hunt N","year":"2005","unstructured":"Hunt N, McHale S. The psychological impact of alopecia. BMJ. 2005, 331:951-3. 10.1136\/bmj.331.7522.951","journal-title":"BMJ"},{"key":"ref90","article-title":"Paranoia and social functioning: a review of mechanisms and interventions","volume":"14","author":"Eres R","year":"2013","unstructured":"Eres R, Bradshaw T, March E. Paranoia and social functioning: a review of mechanisms and interventions. Front Psychiatry. 2013, 14:10649488.","journal-title":"Front Psychiatry"},{"key":"ref91","article-title":"Quality of life, depression, and anxiety in patients with alopecia areata: a systematic review and meta-analysis","volume":"159","author":"Gonz\u00e1lez EJ","year":"2023","unstructured":"Gonz\u00e1lez EJ, Freites N. Quality of life, depression, and anxiety in patients with alopecia areata: a systematic review and meta-analysis. JAMA Dermatol. 2023, 159:417-26.","journal-title":"JAMA Dermatol"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.2147\/CCID.S309215","article-title":"A comprehensive literature review of Jak inhibitors in treatment of alopecia areata","volume":"14","author":"Dillon KL","year":"2021","unstructured":"Dillon KL. A comprehensive literature review of Jak inhibitors in treatment of alopecia areata. Clin Cosmet Investig Dermatol. 2021, 14:691-714. 10.2147\/CCID.S309215","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1186\/s12929-022-00863-6","article-title":"Stem cell secretome as a mechanism for restoring hair loss due to stress, particularly alopecia areata: narrative review","volume":"29","author":"Salhab O","year":"2022","unstructured":"Salhab O, Khayat L, Alaaeddine N. Stem cell secretome as a mechanism for restoring hair loss due to stress, particularly alopecia areata: narrative review. J Biomed Sci. 2022, 29:77. 10.1186\/s12929-022-00863-6","journal-title":"J Biomed Sci"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.3390\/cosmetics7020021","article-title":"Topical minoxidil-loaded nanotechnology strategies for alopecia","volume":"7","author":"Santos AC","year":"2020","unstructured":"Santos AC, Pereira-Silva M, Guerra C, et al.. Topical minoxidil-loaded nanotechnology strategies for alopecia. Cosmetics. 2020, 7:21. 10.3390\/cosmetics7020021","journal-title":"Cosmetics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/324157-alopecia-areata-understanding-the-pathophysiology-and-advancements-in-treatment-modalities","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T14:53:45Z","timestamp":1738335225000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/324157-alopecia-areata-understanding-the-pathophysiology-and-advancements-in-treatment-modalities"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,31]]},"references-count":94,"URL":"https:\/\/doi.org\/10.7759\/cureus.78298","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1,31]]}}}